Therapeutic Drug Monitoring

Papers
(The H4-Index of Therapeutic Drug Monitoring is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology86
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions44
A Review of Synthetic Cathinone–Related Fatalities From 2017 to 202043
Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S.?42
Alternative Sampling Devices to Collect Dried Blood Microsamples: State-of-the-Art41
The Impact of Air Pollution on Neurodegenerative Diseases32
Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range28
Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review27
Pregnancy Alters CYP- and UGT-Mediated Metabolism of Buprenorphine25
Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review25
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs23
Levamisole—a Toxic Adulterant in Illicit Drug Preparations: a Review22
Excretion of Antipsychotics Into the Amniotic Fluid, Umbilical Cord Blood, and Breast Milk: A Systematic Critical Review and Combined Analysis22
Antifungal Drugs TDM: Trends and Update22
Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel21
Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study20
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-1920
Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites20
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling19
Therapeutic Drug Monitoring of Ganciclovir: Where Are We?19
The North American Opioid Epidemic19
0.14011716842651